Figure 1.
Histopathological results of EML4‐ALK fusion‐harboring tumors: (a,b) two acinar adenocarcinomas (cases 1 and 2), (c) one solid adenocarcinoma (case 3), and (d,e) two papillary adenocarcinomas (cases 4 and 5).
Histopathological results of EML4‐ALK fusion‐harboring tumors: (a,b) two acinar adenocarcinomas (cases 1 and 2), (c) one solid adenocarcinoma (case 3), and (d,e) two papillary adenocarcinomas (cases 4 and 5).